How many insider trades does FilingIQ track for LONA?

FilingIQ tracks 30 Form 4 insider transactions for LONA (LeonaBio, Inc.), covering filings from Mar 3, 2026 onwards. 30 of those were filed in the last 90 days.

Are LONA insiders net buyers or net sellers?

Across the full Form 4 history for LONA, 0 transactions (0%) were open-market purchases and 5 (17%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does LONA insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is LONA in?

LeonaBio, Inc. (LONA) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $50.13M.

LONA insider trading

NasdaqCM Healthcare

LeonaBio, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

Last 90 days

Buys / sells

0% / 17%

Market cap

$50.13M

About LeonaBio, Inc.

LeonaBio, Inc., clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. Its product pipeline includes ATH-1105 for the treatment of amyotrophic lateral sclerosis, which is in phase 1 clinical trial; ATH-1020 for the treatment of neurodegenerative diseases, which is phase 1 clinical trial, as well as early compounds which is in preclinical phase. The company was formerly known as Athira Pharma, Inc. and changed its name to LeonaBio, Inc. in January 2026. LeonaBio, Inc. was incorporated in 2011 and is headquartered in Bothell, Washington.

Company website: leonabio.com

LONA insider activity at a glance

FilingIQ has scored 30 insider transactions for LONA since Mar 3, 2026. The most recent filing in our index is dated May 5, 2026.

Across the full history, 0 open-market purchases and 5 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on LONA insider trades is 56.4/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live LONA trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Frequently asked

How many insider trades does FilingIQ track for LONA?: FilingIQ tracks 30 Form 4 insider transactions for LONA (LeonaBio, Inc.), covering filings from Mar 3, 2026 onwards. 30 of those were filed in the last 90 days.
Are LONA insiders net buyers or net sellers?: Across the full Form 4 history for LONA, 0 transactions (0%) were open-market purchases and 5 (17%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does LONA insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is LONA in?: LeonaBio, Inc. (LONA) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $50.13M.

Methodology & sources

Every LONA insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.